Stock listing
Dusseldorf:IUI1 Intuitive Surgical, Inc. Aktie
German listing (Dusseldorf) of Intuitive Surgical, Inc. · home listing NASDAQ:ISRG
Follow Intuitive Surgical, Inc. into a list and get an email when it puts out news.
Share price · DUS:IUI1
€370.10 EUR -4.60 (-1.2%)
Close on Nov 20, 2026
- Day range
- €368.60 – €370.10 EURNov 20, 2026
- Market cap
- €105.8B EURAt the close on Nov 20, 2026 · price × 285.8M shares outstanding
- 52-week range
- €290.59 – €510.40 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €281 EURMedian day 0 shares · 50 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ISRG · Home | $399.05 USD | -21.90 (-5.2%) | 2,691,938 | $407.24 | $410.01 | $397.78 | $420.95 | Close on Nov 20, 2026 |
| TSX:ISRG | $20.63 CAD | -0.38 (-1.8%) | 25,334 | $20.91 | $21.15 | $20.53 | $21.01 | Close on Nov 20, 2026 |
| Xetra:IUI1 | €370.15 EUR | -10.35 (-2.7%) | 649 | €372.10 | €373.90 | €369.70 | €380.50 | Close on Nov 20, 2026 |
| Cboe Canada:ISRG | $20.60 CAD | -0.35 (-1.7%) | 2,339 | $21.06 | $21.06 | $20.60 | $20.95 | Close on Nov 20, 2026 |
| Frankfurt:IUI1 | €365.05 EUR | -15.20 (-4.0%) | 122 | €368.75 | €372.60 | €365.05 | €380.25 | Close on Nov 20, 2026 |
| B3:I1SR34 | 124.62 BRL | +0.29 (+0.2%) | 129 | 125.10 | 125.10 | 124.52 | 124.33 | Close on Nov 19, 2026 |
| Stuttgart:IUI1 | €416.55 EUR | -13.05 (-3.0%) | 57 | €428.20 | €431.30 | €410.60 | €429.60 | Close on Nov 5, 2026 |
| LSE:0R29 | $405.33 USD | -2.24 (-0.5%) | 2,899 | $405.70 | $412.79 | $402.22 | $407.57 | Close on Nov 20, 2026 |
| Munich:IUI1 | €373.15 EUR | -14.80 (-3.8%) | 5 | €371.30 | €373.15 | €371.30 | €387.95 | Close on Nov 20, 2026 |
| Hamburg:IUI1 | €369.80 EUR | -9.60 (-2.5%) | 22 | €369.00 | €370.05 | €369.00 | €379.40 | Close on Nov 20, 2026 |
| Dusseldorf:IUI1 | €370.10 EUR | -4.60 (-1.2%) | — | €368.60 | €370.10 | €368.60 | €374.70 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · DUS:IUI1 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €407.76 | -7.124 | -1.7% | €414.10 | €415.03 | €407.22 | 0 | |
| €414.89 | +22.33 | +5.7% | €421.41 | €425.73 | €410.24 | 0 | |
| €392.56 | -0.103 | 0.0% | €390.25 | €393.04 | €388.59 | 0 | |
| €392.67 | -3.543 | -0.9% | €390.23 | €393.36 | €389.91 | 0 | |
| €396.21 | +4.379 | +1.1% | €387.43 | €398.23 | €381.32 | 0 | |
| €391.83 | -12.76 | -3.2% | €397.84 | €405.15 | €388.29 | 0 | |
| €404.59 | +4.722 | +1.2% | €403.23 | €405.31 | €403.04 | 0 | |
| €399.87 | -0.51 | -0.1% | €396.37 | €403.43 | €391.41 | 0 | |
| €400.38 | -1.437 | -0.4% | €401.23 | €405.59 | €398.09 | 0 | |
| €401.82 | -6.755 | -1.7% | €405.86 | €406.44 | €399.80 | 0 | |
| €408.57 | +16.16 | +4.1% | €394.63 | €410.92 | €392.99 | 0 | |
| €392.41 | +12.18 | +3.2% | €380.07 | €396.43 | €380.06 | 0 | |
| €380.23 | -12.75 | -3.2% | €359.82 | €383.26 | €357.61 | 0 | |
| €392.98 | +9.81 | +2.6% | €385.81 | €393.01 | €384.43 | 0 | |
| €383.17 | +1.256 | +0.3% | €381.37 | €383.54 | €378.90 | 3 | |
| €381.91 | +4.918 | +1.3% | €381.30 | €384.06 | €380.61 | 0 | |
| €376.99 | +1.10 | +0.3% | €373.10 | €377.05 | €373.04 | 0 | |
| €375.89 | -2.148 | -0.6% | €376.87 | €379.53 | €375.42 | 0 | |
| €378.04 | -2.299 | -0.6% | €379.36 | €382.28 | €375.04 | 0 | |
| €380.34 | +2.95 | +0.8% | €379.96 | €380.52 | €379.48 | 0 | |
| €377.39 | +8.429 | +2.3% | €371.57 | €381.99 | €370.85 | 0 | |
| €368.96 | +2.102 | +0.6% | €368.07 | €372.70 | €367.71 | 0 | |
| €366.86 | +8.067 | +2.2% | €358.95 | €372.70 | €355.51 | 0 | |
| €358.79 | +0.741 | +0.2% | €360.23 | €360.23 | €358.00 | 0 | |
| €358.05 | +3.937 | +1.1% | €348.91 | €358.93 | €348.40 | 0 | |
| €354.12 | -2.549 | -0.7% | €354.61 | €360.41 | €352.33 | 0 | |
| €356.66 | -4.597 | -1.3% | €358.36 | €363.25 | €355.86 | 0 | |
| €361.26 | +0.051 | 0.0% | €362.65 | €363.10 | €357.66 | 2 | |
| €361.21 | -0.057 | 0.0% | €363.71 | €363.95 | €360.94 | 0 | |
| €361.27 | +12.09 | +3.5% | €355.99 | €366.75 | €355.82 | 0 | |
| €349.18 | -1.731 | -0.5% | €350.42 | €355.02 | €349.18 | 0 | |
| €350.91 | -0.725 | -0.2% | €350.59 | €351.90 | €350.58 | 0 | |
| €351.64 | +2.07 | +0.6% | €353.64 | €355.44 | €345.39 | 0 | |
| €349.57 | +2.642 | +0.8% | €348.75 | €349.62 | €348.62 | 0 | |
| €346.93 | +6.703 | +2.0% | €344.19 | €347.08 | €343.75 | 0 | |
| €340.22 | +6.974 | +2.1% | €335.09 | €342.11 | €333.74 | 0 | |
| €333.25 | +4.14 | +1.3% | €330.29 | €333.67 | €327.38 | 0 | |
| €329.11 | +5.829 | +1.8% | €326.29 | €332.03 | €322.73 | 0 | |
| €323.28 | -2.741 | -0.8% | €322.69 | €324.44 | €318.86 | 0 | |
| €326.02 | +11.93 | +3.8% | €316.01 | €328.76 | €314.29 | 2 | |
| €314.09 | +6.15 | +2.0% | €312.10 | €318.44 | €309.57 | 0 | |
| €307.94 | +5.686 | +1.9% | €304.54 | €311.55 | €301.33 | 0 | |
| €302.25 | -2.247 | -0.7% | €301.63 | €303.28 | €300.17 | 3 | |
| €304.50 | -6.626 | -2.1% | €310.83 | €312.28 | €304.31 | 0 | |
| €311.13 | -4.072 | -1.3% | €313.71 | €315.81 | €311.09 | 0 | |
| €315.20 | -3.597 | -1.1% | €317.06 | €317.06 | €313.81 | 0 | |
| €318.79 | -1.646 | -0.5% | €319.57 | €319.57 | €318.19 | 3 | |
| €320.44 | +3.173 | +1.0% | €320.32 | €329.53 | €317.61 | 0 | |
| €317.27 | -4.915 | -1.5% | €320.19 | €320.28 | €313.67 | 0 | |
| €322.18 | +3.426 | +1.1% | €321.45 | €323.18 | €321.09 | 0 | |
| €318.76 | +3.75 | +1.2% | €316.83 | €318.85 | €316.04 | 0 | |
| €315.01 | -4.36 | -1.4% | €315.81 | €316.69 | €314.37 | 0 | |
| €319.37 | +2.502 | +0.8% | €319.01 | €321.08 | €318.35 | 0 | |
| €316.86 | -6.171 | -1.9% | €320.72 | €322.77 | €315.01 | 0 | |
| €323.04 | -2.583 | -0.8% | €323.59 | €327.69 | €321.52 | 0 | |
| €325.62 | +3.136 | +1.0% | €325.56 | €327.71 | €323.00 | 3 | |
| €322.48 | -21.19 | -6.2% | €338.92 | €342.57 | €322.13 | 33 |
Splits
2 splits since 2017 · DUS:IUI1 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split | |
| 3-for-1 | Split |
- Ticker
- Dusseldorf:IUI1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Intuitive Appoints Aaron Martin to its Board of Directors
Latest earnings call · Oct 20, 2026
Intuitive Surgical (NASDAQ:ISRG) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Jan 14, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 27 slides
Latest news
Intuitive Appoints Aaron Martin to its Board of Directors
Nov 2, 2026
Closed €392.67 (-0.9%) on Nov 3, 2026
Q3 2026 Financial Data Tables
Oct 30, 2026
Closed €391.83 (-3.2%) on Oct 30, 2026
Intuitive Announces Third Quarter Earnings
Oct 20, 2026
Closed €380.23 (-3.2%) on Oct 21, 2026
Intuitive announces expanded indication for da Vinci SP in Europe
Sep 14, 2026
Closed €326.02 (+3.8%) on Sep 14, 2026
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Sep 8, 2026
Closed €302.25 (-0.7%) on Sep 9, 2026
Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia
Aug 17, 2026
Closed €338.51 (-2.1%) on Aug 17, 2026
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
Jul 27, 2026
Closed €312.34 (+5.8%) on Jul 27, 2026
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
Jul 23, 2026
Closed €293.60 (-2.8%) on Jul 23, 2026
Q2 2026 Financial Data Tables
Jul 16, 2026
Closed €306.88 (-12.2%) on Jul 17, 2026
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
May 28, 2026
Closed €360.70 (+0.3%) on May 29, 2026
Intuitive Surgical, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 26 in the last 12 months · 79 in all · newest Nov 2, 2026 · oldest 2019
- Calls
- 32 calls with a replay · 32 with a transcript · latest Oct 20, 2026
- Decks
- 15 decks · latest Jan 14, 2026
Where Intuitive Surgical, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ISRG · Home listing | NASDAQ | United States | USD |
| gettex:IUI1 | gettex | Germany | EUR |
| Tradegate:IUI1 | Tradegate | Germany | EUR |
| LS Exchange:888024 | LS Exchange | Germany | EUR |
| TSX:ISRG | TSX | Canada | CAD |
| Xetra:IUI1 | Xetra | Germany | EUR |
| SET:ISRG01 | SET | Thailand | THB |
| BCBA:ISRG | BCBA | Argentina | ARS |
| SET:ISRG06 | SET | Thailand | THB |
| Cboe Canada:ISRG | Cboe Canada | Canada | CAD |
| Frankfurt:IUI1 | Frankfurt | Germany | EUR |
| BMV:ISRG | BMV | Mexico | MXN |
| SET:ISRG19 | SET | Thailand | THB |
| Milan:1ISRG | Milan | Italy | EUR |
| B3:I1SR34 | B3 | Brazil | BRL |
| BOATS:ISRG | BOATS | United States | USD |
| Stuttgart:IUI1 | Stuttgart | Germany | EUR |
| Lang & Schwarz:888024 | Lang & Schwarz | Germany | EUR |
| LSE:0R29 | LSE | United Kingdom | USD |
| Frankfurt:IUI | Frankfurt | Germany | EUR |
| VIE:ISRG | Vienna | Austria | EUR |
| EUROTLX:4ISRG | EUROTLX | Italy | EUR |
| BIVA:ISRG | BIVA | Mexico | MXN |
| Munich:IUI1 | Munich | Germany | EUR |
| BX Swiss:IUI1 | BX Swiss | Switzerland | CHF |
| BCBA:ISRGD | BCBA | Argentina | USD |
| Hamburg:IUI1 | Hamburg | Germany | EUR |
| BCBA:ISRGC | BCBA | Argentina | USD |
| Hanover:IUI1 | Hanover | Germany | EUR |
| Dusseldorf:IUI1 · This page | Dusseldorf | Germany | EUR |
| Turquoise:ISRGN | Turquoise | United Kingdom | USD |
| BCBA:ISRG.CI | BCBA | Argentina | ARS |
| SET:ISRG80 | SET | Thailand | THB |
Valuation
P/E 46.8× against a median of 26.6×: 8th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $134.3B USD
- P/E
- 46.8×
- EV/sales
- 11.6×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 8.7×
- Gross margin
- 67.2%
- Operating margin
- 28.4%
- Net margin
- 25.5%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.90
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Intuitive Surgical, Inc. · NASDAQ:ISRG | US$138.3B | US$134.3B | 46.8× | 11.6× | n/a | 8.7× | 25.5% | 0.0× | 0.90 |
| Medtronic plc. · NYSE:MDT | US$127.8B | US$144.6B | 24.4× | 3.9× | 14.9× | 2.5× | 13.9% | 0.5× | 0.15 |
| Stryker Corporation · NYSE:SYK | US$118.0B | US$129.7B | 32.6× | 4.9× | n/a | 5.0× | 13.8% | 0.6× | 0.25 |
| Boston Scientific Corporation · NYSE:BSX | US$60.85B | US$71.15B | 17.4× | 3.4× | n/a | 2.4× | 16.6% | 0.4× | 0.31 |
| Edwards Lifesciences Corporation · NYSE:EW | US$58.56B | US$54.52B | 57.3× | 8.2× | 33.8× | 5.4× | 15.3% | 0.1× | 0.54 |
| Becton, Dickinson and Company · NYSE:BDX | US$57.96B | US$70.76B | 61.6× | 3.2× | 14.8× | 2.4× | 4.2% | 0.6× | 0.29 |
| Siemens Healthineers AG · XETR:SHL | US$52.77B | US$49.52B | 21.7× | 1.9× | 10.3× | 2.4× | 9.4% | 0.0× | n/a |
| GE HealthCare Technologies Inc. · NASDAQ:GEHC | US$36.46B | US$43.61B | 16.9× | 2.0× | 13.7× | 3.1× | 10.0% | 0.9× | 0.65 |
| Alcon AG · SIX:ALC | US$35.86B | US$38.74B | 54.0× | 3.5× | 16.1× | 1.6× | 6.1% | 0.2× | n/a |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760 | US$33.43B | US$30.45B | 28.7× | 5.9× | n/a | 5.4× | 22.4% | 0.0× | n/a |
| ResMed Inc. · NYSE:RMD | US$33.14B | US$32.54B | 20.8× | 5.7× | 15.6× | 5.6× | 27.8% | 0.1× | 0.48 |
| Median of the others | US$55.36B | US$52.02B | 26.6× | 3.7× | 14.9× | 2.8× | 13.9% | 0.3× | 0.31 |
Forecasts
19 strong buy · 7 buy · 6 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 486.57 USD · Analysts' mean
- EPS, year to Dec 2026
- 11.25 · 27 analysts
- Revenue, year to Dec 2026
- 11.93B · 31 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Monica P. Reed | President and CEO of UChicago Medicine Advent Health |
| Catherine Mohr | Intuitive Foundation President |
| Dave Rosa | President |
| Sreelakshmi Kolli | Executive Vice President, Chief Product and Digital Officer |
| Gary S. Guthart | Executive Chair of the Board of Directors |
Board
| Director | Role |
|---|---|
| Keith R. Leonard | Chairman, Unity Biotechnology, Inc |
| Aaron Martin | Director (from Jan 1, 2027) |
| Craig H. Barratt | Lead Independent Director, Intuitive |
Events
Calls
| Call | When | Status |
|---|---|---|
| Intuitive Surgical (NASDAQ:ISRG) Q3 2026 Earnings Call | Tue, Oct 20, 2026 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q2 2026 Earnings Call | Thu, Jul 16, 2026 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q1 2026 Earnings Call | Tue, Apr 21, 2026 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q4 2025 Earnings Call | Thu, Jan 22, 2026 · 4:00 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q3 2025 Earnings Call | Tue, Oct 21, 2025 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q2 2025 Earnings Call | Tue, Jul 22, 2025 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q1 2025 Earnings Call | Tue, Apr 22, 2025 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q4 2024 Earnings Call | Thu, Jan 23, 2025 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q3 2024 Earnings Call | Thu, Oct 17, 2024 · 4:30 PM ET | Replay |
| Intuitive Surgical (NASDAQ:ISRG) Q2 2024 Earnings Call | Thu, Jul 18, 2024 · 4:30 PM ET | Replay |
All 32 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 20, 2026 · After close | −2.3% |
| Q2 2026 | Jul 16, 2026 · After close | −14.2% |
| Q1 2026 | Apr 21, 2026 · After close | +7.2% |
| Q4 2025 | Jan 22, 2026 · After close | −0.3% |
| Q3 2025 | Oct 21, 2025 · After close | +13.9% |
| Q2 2025 | Jul 22, 2025 · After close | −1.8% |
| Q1 2025 | Apr 22, 2025 · After close | +1.9% |
| Q4 2024 | Jan 23, 2025 · After close | −4.0% |
| Q3 2024 | Oct 17, 2024 · After close | +10.0% |
| Q2 2024 | Jul 18, 2024 · After close | +9.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 18, 2024 · After close | −1.7% |
| Q4 2023 | Jan 23, 2024 · After close | −0.4% |
| Q3 2023 | Oct 19, 2023 · After close | −2.4% |
| Q2 2023 | Jul 20, 2023 · After close | −3.2% |
| Q1 2023 | Apr 18, 2023 · After close | +10.9% |
| Q4 2022 | Jan 24, 2023 · After close | −5.5% |
| Q3 2022 | Oct 18, 2022 · After close | +9.0% |
| Q2 2022 | Jul 21, 2022 · After close | −5.7% |
| Q1 2022 | Apr 21, 2022 · After close | −14.3% |
| Q4 2021 | Jan 20, 2022 · After close | −7.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| J.P. Morgan Healthcare Conference 2026 | Conference | 27 slides | Jan 14, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 19 slides | 2026 |
| Q2 2026 Earnings Presentation | Earnings | 19 slides | 2026 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | Apr 22, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 27 slides | Oct 17, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 27 slides | Jul 18, 2024 |
| Investor Presentation (June 2024) | Investor deck | 4 slides | June 2024 |
| Q1 2024 Earnings Presentation | Earnings | 27 slides | Apr 18, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 21 slides | Oct 19, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 21 slides | Jul 20, 2023 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2023 Earnings Presentation | Earnings | 21 slides | Apr 18, 2023 |
| Investor Presentation (March 2023) | Investor deck | 11 slides | March 2023 |
| Investor Presentation (December 2018) | Investor deck | 43 slides | December 2018 |
| Investor Presentation (August 2018) | Investor deck | 14 slides | August 2018 |
| Fact Sheet | Fact sheet | 1 slide |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1B | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.14B | 2.71B |
| Cost of revenue | 3.42B | 2.72B | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.8M | 814.3M |
| Gross profit | 6.64B | 5.63B | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.20B | 1.89B |
| Research and development | 1.31B | 1.15B | 998.8M | 879.0M | 671.0M | 595.1M | 557.3M | 418.1M | 328.6M | 239.6M |
| Selling, general and administrative | 2.38B | 2.14B | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.6M | 810.5M | 703.6M |
| Operating income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B | 1.37B | 1.20B | 1.06B | 949.7M |
| Depreciation and amortization | 600.0M | 439.0M | 382.0M | 326.0M | 280.0M | 221.0M | 157.0M | 105.9M | 82.1M | 70.7M |
| EBITDA | 3.55B | 2.79B | 2.15B | 1.90B | 2.10B | 1.27B | 1.53B | 1.31B | 1.15B | 1.02B |
| Income before tax | 3.31B | 2.67B | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 985.3M |
| Income tax | 434.8M | 336.3M | 141.6M | 262.4M | 162.2M | 140.2M | 120.4M | 154.5M | 433.9M | 247.0M |
| Net income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 670.9M | 738.3M |
| Earnings per share, basic | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 9.92 | 6.01 | 6.43 |
| Earnings per share, diluted | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 9.49 | 5.77 | 6.26 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.37B | 2.03B | 2.75B | 1.58B | 1.29B | 1.62B | 1.17B | 857.9M | 648.2M | 1.04B |
| Short-term investments | 2.57B | 1.99B | 2.47B | 2.54B | 2.91B | 3.49B | 2.05B | 2.21B | 1.31B | 1.52B |
| Receivables | 1.53B | 1.23B | 1.13B | 942.1M | 782.7M | 645.5M | 645.2M | 682.3M | 507.9M | 430.2M |
| Inventory | 1.84B | 1.49B | 1.22B | 893.2M | 587.1M | 601.5M | 595.5M | 409.0M | 241.2M | 182.3M |
| Current assets | 9.78B | 7.11B | 7.89B | 6.25B | 5.84B | 6.63B | 4.66B | 4.33B | 2.81B | 3.25B |
| Property, plant and equipment | 5.34B | 4.65B | 3.54B | 2.37B | 1.88B | 1.58B | 1.27B | 812.0M | 613.1M | 458.4M |
| Goodwill | 370.3M | 347.5M | 348.7M | 348.5M | 343.6M | 336.7M | 307.2M | 240.6M | 201.1M | 201.1M |
| Total assets | 20.5B | 18.7B | 15.4B | 13.0B | 13.6B | 11.2B | 9.73B | 7.85B | 5.78B | 6.49B |
| Accounts payable | 255.1M | 193.4M | 188.7M | 147.0M | 121.2M | 81.6M | 123.5M | 100.7M | 82.5M | 68.5M |
| Current liabilities | 2.01B | 1.75B | 1.66B | 1.42B | 1.15B | 965.2M | 1.03B | 820.6M | 662.8M | 596.5M |
| Total liabilities | 2.52B | 2.21B | 2.04B | 1.86B | 1.60B | 1.41B | 1.45B | 1.16B | 996.4M | 709.1M |
| Shareholders' equity | 17.8B | 16.4B | 13.3B | 11.0B | 11.9B | 9.73B | 8.26B | 6.68B | 4.78B | 5.78B |
| Shares outstanding | 355.1M | 356.6M | 352.3M | 350.0M | 357.7M | 353.1M | 116.0M | 114.5M | 112.3M | 116.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.03B | 2.42B | 1.81B | 1.49B | 2.09B | 1.48B | 1.60B | 1.17B | 1.14B | 1.09B |
| Capital spending | -539.8M | -1.11B | -1.06B | -532.4M | -339.5M | -341.5M | -425.6M | -187.4M | -190.7M | -53.9M |
| Free cash flow | 2.49B | 1.30B | 749.6M | 958.4M | 1.75B | 1.14B | 1.17B | 982.2M | 953.2M | 1.03B |
| Cash from investing | 665.8M | -3.27B | -360.1M | 1.37B | -2.46B | -940.6M | -1.15B | -1.05B | 378.7M | -1.28B |
| Cash from financing | -2.36B | 150.9M | -287.6M | -2.57B | 43.0M | -85.7M | -168.4M | 126.3M | -1.91B | 514.4M |
| Share buybacks | -2.30B | 0 | -416.3M | -2.61B | 0 | -134.3M | -269.5M | 0 | -2.27B | -42.5M |
| Change in cash | 1.34B | -707.7M | 1.17B | 294.7M | -332.5M | 455.9M | 273.2M | 246.2M | -388.4M | 322.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Nov 19, 2026 | Offer document | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 4, 2026 | Other filings | SEC |
| 8-K · Current report | Nov 2, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Nov 2, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 30, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 23, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Oct 21, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 20, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 10, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 27, 2026 | Current report | SEC |
| S-8 · Registration statement for employee plans | Jul 21, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Jul 21, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 16, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 1, 2026 | Other filings | SEC |
| 8-K · Current report | May 28, 2026 | Management or board change | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 21, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 11, 2026 | Other filings | SEC |
| 8-K · Current report | May 4, 2026 | Management or board change | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 29, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 28, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 27, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Apr 22, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 21, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Mar 13, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Mar 13, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Mar 13, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 2, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 27, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 11, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 10, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 5, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 3, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 29, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 27, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 22, 2026 | Results | SEC |
| 8-K · Current report | Jan 14, 2026 | Results | SEC |
| 8-K · Current report | Dec 18, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 29, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 24, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Oct 22, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 21, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 4, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 29, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 25, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Jul 23, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Jul 23, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 22, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 6, 2025 | Other filings | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Intuitive Surgical, Inc.’s releases · as of Oct 15, 2026
- Common shares
- 346,643,718
- Fully diluted
- 346,643,718
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 346,643,718 | Oct 15, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 15, 2026 | 346,643,718 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| D. Keith Grossman Other companies: Alcon AG (Board Member · Since at least May 16, 2026); MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); Outset Medical, Inc. (Lead Independent Director · Since at least Sep 14, 2020); Nevro Corp (Director · Mar 19, 2019 – Apr 3, 2025 · Past); Zeltiq Aesthetics Inc (Director · Oct 24, 2013 – Apr 28, 2017 · Past); Conceptus Inc (President & CEO · Dec 13, 2011 – Jun 5, 2013 · Past); Kyphon Inc (Director · Apr 24, 2007 – Nov 2, 2007 · Past) | Director · May 19, 2006 – Apr 23, 2010 · Past |
| Keith R. Leonard Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Sep 2, 2021); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 21, 2024 · Past); Kythera Biopharmaceuticals Inc (President & CEO, Director · Jan 29, 2012 – Oct 1, 2015 · Past); Affymax Inc (Director · Dec 6, 2007 – Jun 13, 2012 · Past); Aryx Therapeutics Inc (Director · Nov 7, 2007 – Apr 30, 2010 · Past) | Chairman, Unity Biotechnology, Inc · Since at least Jan 28, 2016 |
| Lewis Chew Other companies: Arista Networks, Inc. (Board Member · Since at least Jul 19, 2021); Cadence Design Systems, Inc. (Director · Since at least Mar 15, 2020); Dolby Laboratories (EVP & Chief Financial Officer · Jun 17, 2013 – Aug 17, 2021 · Past); PG&E Corporation (Director · Jun 11, 2013 – May 22, 2018 · Past) | Director · Since at least Apr 25, 2024 |
| Marshall Mohr Other companies: Veeva Systems Inc. (Director · Since at least Jan 21, 2022); Pacific Biosciences of California, Inc. (Director · Since at least Jan 18, 2012); Plantronics Inc (Director · Jul 27, 2010 – Aug 29, 2022 · Past); Atheros Communications Inc (Director · May 24, 2010 – May 24, 2011 · Past) | Director · Apr 30, 2010 – Nov 5, 2026 · Past |
| Myriam Curet Other companies: Mobia Medical, Inc. (Board Member · Since at least Jul 30, 2026); Inspire Medical Systems, Inc. (Director · Since at least Dec 21, 2023); Stereotaxis, Inc. (Director · Since at least Jul 22, 2021); Nektar Therapeutics (Director · Dec 12, 2019 – Sep 18, 2023 · Past) | EVP & Chief Medical Officer · Since at least Dec 31, 2018 |
| Don R Kania Other companies: NanoString Technologies Inc (Director · Oct 30, 2019 – Jun 16, 2022 · Past); American Science & Engineering Inc (Director · Sep 9, 2016 – Sep 9, 2016 · Past); FEI Company (See Remarks, Director · May 17, 2016 – Sep 19, 2016 · Past) | Director · Jul 31, 2018 – Apr 25, 2024 · Past |
| Jamie Samath Other companies: KLA Corporation (Director · Since at least Apr 30, 2025); Atmel Corp (ATML) (VP & Corporate Controller · Dec 16, 2011 – Feb 15, 2013 · Past); National Semiconductor Corp (VP, Corporate Controller · Nov 16, 2010 – Sep 23, 2011 · Past) | EVP & CFO & Enterprise Technol · Since at least May 7, 2013 |
| Patricia L Wadors Other companies: Procore Technologies, Inc. (Chief Talent Officer · May 19, 2021 – Apr 1, 2022 · Past); Accolade, Inc. (Director · Jul 1, 2020 – Apr 8, 2025 · Past); ServiceNow, Inc. (Chief Talent Officer · May 7, 2019 – Aug 17, 2020 · Past) | SVP Chief Human Resources Offi · Since at least Jan 29, 2026 |
| Robert W. Duggan Other companies: Summit Therapeutics Inc. (Co-CEO & Chairman of the Board · Since at least Sep 18, 2020); Pulse Biosciences, Inc (Director · Since at least Nov 2, 2017); Pharmacyclics Inc (Chairman and CEO, Director · Sep 17, 2007 – May 26, 2015 · Past) | Director · Feb 15, 2006 – May 18, 2011 · Past |
| Amal M. Johnson Other companies: Essex Property Trust, Inc. (Director · Since at least May 11, 2021); CalAmp Corp (Director · May 13, 2021 – Jul 28, 2021 · Past) | Director · Since at least Apr 22, 2021 |
All 42 people
| Person | Seat |
|---|---|
| Craig H. Barratt Other companies: Astera Labs, Inc. (Director · Since at least Jun 4, 2026); Intel Corporation (Director · Since at least Mar 3, 2026) | Director · Since at least May 15, 2025 |
| Gary S. Guthart Other companies: Illumina, Inc. (Director · Dec 1, 2017 – May 21, 2025 · Past); Affymetrix Inc (Director · Mar 31, 2016 – Mar 31, 2016 · Past) | Executive Chair of the Board of Directors · Since at least Aug 1, 2016 |
| Jami Nachtsheim Other companies: Cerus Corporation (Chair · Since at least Jun 1, 2022); Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past) | Director · Since at least Apr 22, 2022 |
| Sreelakshmi Kolli Other companies: Zimmer Biomet Holdings, Inc. (Director · Since at least Feb 18, 2021); Align Technology, Inc. (SVP & Mng Dir Info Tech · Nov 7, 2016 – Feb 20, 2020 · Past) | Executive Vice President, Chief Product and Digital Officer · Since at least Oct 27, 2023 |
| Aaron Martin Other companies: Humana Inc. (President, Medicare Advantage · Since at least Jan 26, 2026) | Director (from Jan 1, 2027) · Since at least Nov 2, 2026 |
| Amy L Ladd Other companies: Allakos Inc (Director · Jul 21, 2022 – May 15, 2025 · Past) | Director · Since at least Aug 1, 2019 |
| Benjamin B Gong Other companies: Pacific Biosciences of California, Inc. (Interim CFO and PAO · Aug 8, 2020 – Aug 8, 2020 · Past) | Vice President, Finance · Feb 7, 2006 – Mar 17, 2006 · Past |
| Gary Loeb Other companies: Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 25, 2021 – Mar 23, 2021 · Past) | EVP & Chief Legal and Complian · Since at least Sep 27, 2022 |
| Mark J Rubash Other companies: iRhythm Holdings, Inc. (Director · Since at least Jun 18, 2021) | Director · Apr 22, 2021 – Apr 25, 2025 · Past |
| Monica P. Reed Other companies: Isleworth Healthcare Acquisition Corp (Director · Sep 8, 2021 – Sep 8, 2021 · Past) | President and CEO of UChicago Medicine Advent Health · Since at least Apr 22, 2021 |
| William J Mercer Other companies: Zoll Medical Corp (Director · May 30, 2006 – Jun 2, 2006 · Past) | Director · May 19, 2006 – Jun 2, 2006 · Past |
| Alan J Levy | Director · Apr 22, 2010 – Apr 25, 2024 · Past |
| Augusto V Castello | SVP Product Ops · Apr 21, 2011 – Feb 15, 2013 · Past |
| Brian Edward Miller | EVP & Chief Digital Officer · Since at least Nov 10, 2025 |
| Catherine Mohr | Intuitive Foundation President · Since at least Jan 27, 2025 |
| Colin Morales | GM & SVP Secondary Mkt Equip & · Apr 21, 2011 – Feb 7, 2017 · Past |
| Dave Rosa | President · Since at least Jul 13, 2026 |
| David J Rosa | Chief Executive Officer (CEO), Director · Since at least Apr 21, 2011 |
| Eric H Halvorson | Director · Mar 14, 2016 – Apr 25, 2016 · Past |
| Fredrik Widman | VP Corporate Controller · Since at least Feb 10, 2024 |
| George Stalk Jr | Director · Oct 19, 2007 – Apr 20, 2017 · Past |
| Henry L Charlton | EVP & Chief Commercial and Mkt · Since at least Jan 1, 2022 |
| Iman Jeddi | SVP & GM da Vinci Platforms & · Since at least Jan 29, 2026 |
| Joseph C Beery | Director · Since at least Apr 23, 2020 |
| Mark Brosius | EVP & Chief Mfg and Supply Cha · Since at least Feb 1, 2024 |
| Mark J Meltzer | SVP General Counsel & CCO · Jul 27, 2015 – Jun 7, 2018 · Past |
| Michele DiMartino | See Remarks · Jan 25, 2023 – Feb 28, 2023 · Past |
| Reiter Kara Andersen | Sr VP General Counsel & CCO · Aug 29, 2022 – Aug 29, 2022 · Past |
| Richard Michael Epstein | Sr. Vice President, Marketing · Feb 5, 2007 – Feb 15, 2007 · Past |
| Robert DeSantis | EVP & Chief Strategy & Corp Op · Apr 1, 2020 – Apr 25, 2025 · Past |
| Salvatore Brogna | EVP & Chief Operating Officer · Apr 21, 2011 – Dec 2, 2019 · Past |
| Thorax. Published | CEO MESSAGE · Mar 17, 2026 – Nov 5, 2026 · Past |
Log in to ask 6ix AI your own questions about Intuitive Surgical, Inc.